Subscribe to Specialty Providers

Specialty Providers

Q&A: Option Care's John Rademacher

 - 
04/29/2019

When the ink dries on the planned merger of two of the country’s leading home infusion services providers, it will form an organization that is deeply committed to patient care, says John Rademacher, CEO of the combined company of Option Care and BioScri

O&P stakeholders take next steps to preserve access

 - 
04/26/2019

WASHINGTON – O&P stakeholders plan to use a recent massive fraud takedown involving medically unnecessary knee and back braces to advance upcoming legislation.

New PHS CEO, inspired by patients, seeks innovation

 - 
04/26/2019

ROSEVILLE, Minn. – New CEO Cameo Zehnder has built an entire career at Pediatric Home Service, an independent pediatric homecare company based here.

Arriva execs settle allegations

 - 
04/25/2019

NASHVILLE, Tenn. – Two former Arriva Medical executives have settled allegations they violated the False Claims Act by agreeing to pay $500,000 each.

Vent providers fear worst

‘We’re really just being asked to cut our rate and offer no other support’
 - 
04/05/2019

YARMOUTH, Maine – The lack of clear guidance for non-invasive ventilators could make it difficult to calculate bids for the product and could, ultimately, compromise patient care, say providers.

Mystery surrounds nat’l mail-order program for diabetes testing supplies

 - 
03/29/2019

WASHINGTON – With the national mail-order program for diabetes testing supplies on hold indefinitely, it’s anybody’s guess what will happen next.

AOPA criticizes ‘unscrupulous’ providers

 - 
03/28/2019

ALEXANDRIA, Va. – The American Orthotic & Prosthetic Association is “strongly opposed” to lead-generation marketing for orthoses, a business practice that it says is responsible for an increase in fraud and abuse, the association said in a statement today.

OIG: Three strips dominate market

 - 
03/27/2019

WASHINGTON – The top three types of diabetes test strips accounted for just over half of the non-mail order market, and the top 10 types accounted for approximately 93% of the market, according to a new report from the Office of Inspector General.

Option Care positions itself as ‘partner of choice’

 - 
03/22/2019

DENVER, Colo., and BANNOCKBURN, Ill. – Option Care CEO John Rademacher says its merger with BioScrip will create a “powerful, independent platform” in the growing $100 million infusion market.

Roche sues pharmacy network

 - 
03/22/2019

NEW YORK – Roche Diagnostics has filed a lawsuit against the former executives of a Utah-based company, alleging nationwide fraud involving test strips.

Pages